Our Latest Thinking

Andrew Croshaw, Jennifer Colamonico, and special guest Brett Glover, Partner and Healthcare Deal Advisor at KPMG, discussed the most impactful healthcare trends for investors in 2021. A recording of the discussion can be found below. Follow our company LinkedIn page to join the live broadcasts, and review upcoming topics and speakers here!

Repertoire Magazine: David Muhlestein was featured extensively in a recent article in Repertoire Magazine on the effectiveness of affordable care organizations (ACOs). In the article, he is quoted discussing cost-savings benefits for physicians and Medicare patients through ACOs, the ability ACOs have to deliver high-quality care, and the superiority of physician-led ACOs compared to hospital […]

The dominating stories of 2020 have been the pandemic and the presidential election, but will 2021 be the same kind of rollercoaster? As the vaccination campaign begins, how quickly will we see stability? As a new president takes the reins, what will his healthcare priorities look like both for COVID and beyond it? On Thursday, […]

Governor Mike Leavitt, Andrew Croshaw, and healthcare futurist, Ian Morrison, had an engaging discussion reflecting on 2020 and key lessons learned as the healthcare industry prepares for 2021. A recording of the discussion can be found below. Follow our company LinkedIn page to join future broadcasts, and review upcoming topics and speakers here!

Health Affairs Blog: David Muhlestein, chief strategy and chief research officer for Leavitt Partners, published a blog on Health Affairs titled “The Coming Crisis for the Medicare Trust Fund.” Medicare was established through legislation in 1965 to ensure that senior citizens would have access to health care in the later years of their lives. Shortly after […]

AJMC: The American Journal of Accountable Care (AJMC) recently announced the addition of 9 new members to its editorial board, including David Muhlestein, chief strategy and chief research officer for Leavitt Partners. Congratulations and good luck to David in his new editorial position! Read the full article here.

AJMC: David Muhlestein, chief strategy and chief research officer for Leavitt Partners, recently co-authored a study on Medicare accountable care organization (ACO) attribution methods. The study examines patient survival rates and spending by Medicare for ACO populations based on whether the ACOs use prospective or retrospective claims-based attribution methods. Read the full article here.

Andrew Croshaw, Anne Marie Polak, and Chase Titensor discussed at a high-level, the COVID-19 vaccine development and distribution process. With submissions from both Pfizer and Moderna under consideration at the FDA, can we be hopeful that a vaccine on the horizon signals a return to “normal”? A recording of the discussion can be found below. […]